Ignite Creation Date:
2025-12-25 @ 5:07 AM
Ignite Modification Date:
2026-03-09 @ 12:55 PM
Study NCT ID:
NCT06098027
Status:
COMPLETED
Last Update Posted:
2023-11-21
First Post:
2023-09-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of [14C]CS0159 in China Healthy Subjects
Sponsor:
Cascade Pharmaceuticals, Inc
Organization:
Study Overview
Official Title:
[14C]CS0159 in Chinese Healthy Subjects for Mass Balance Phase I Study
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study of \[14C\]CS0159 in China Healthy Subjects.
Detailed Description:
A phase I study to quantify the total mass balance in healthy subjects after a single dose of \[14C\]CS0159.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: